poster

Patient Perspectives on Major Depressive Disorder Care to Inform Patient-Centered Approaches

To better understand patients’ experiences and perceptions of their major depressive disorder (MDD) care, we designed a 21-item survey to capture patient perceptions of their MDD symptoms...

10/26/2023

Patient Preferences and Nocturnal Experiences With Oxybate Therapy for Narcolepsy: RESTORE Study Interim Analysis

RESTORE (NCT04451668), an ongoing open-label/switch study evaluating the safety/tolerability of once-nightly sodium oxybate (ON-SXB), included 2 questionnaires administered to participant...

10/26/2023

Mobile Technology-Supported Shared Decision-Making and Goal Setting for Management of Depression in Primary Care

Mobile-based apps have potential to assist clinicians and patients in the shared decision-making (SDM) process for management of major depressive disorder (MDD). Primary Care Path is a pr...

10/26/2023

Multiple Factors Underlying Diagnostic Etiology of Psychosis: A Case Report.

27 year old male with history of HIV infection and substance abuse disorder arrived at the ER presenting aggressive behavior, errors of judgment and conduct, ego dystonic complex, auditor...

10/26/2023

No Signs of MDMA-Related Histopathological Changes to CNS in Rats and Dogs in A 28-Day Repeated Oral Dose Neurotoxicity Study

3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy is being investigated as a potential treatment option for patients with posttraumatic stress disorder (PTSD). Previous animal MDM...

10/26/2023

Olanzapine/Samidorphan Effects on Weight Gain: A Pooled Analysis of Phase 2 and 3 Randomized, Double-Blind Studies

This pooled post hoc analysis compared the effects of a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine on body weight after 12 weeks of treatment in patients with s...

10/26/2023

Medical Management of Capgras Syndrome with Underlying Lewy Body Dementia in an Elderly Patient with Mild Cognitive Impairment

A case report to evaluate and discuss the underlying pathology associated with both Lewy Body Dementia and Capgras syndrome, as well as the medical management and subsequent interventions...

10/26/2023

Medication Burden in Patients With Major Depressive Disorder Enrolled in Medicare Advantage Plans.

This study assessed real-world antidepressant treatment patterns and medication burden among Medicare Advantage Prescription beneficiaries with major depressive disorder (MDD). Adherence ...

10/26/2023

Mental Health Comorbidities Among Patients With Chronic Medical Conditions and Alcohol Use Disorder

The aim of this retrospective cohort study was to describe mental health comorbidities among patients with selected ambulatory-care sensitive conditions and comorbid alcohol use disorder ...

10/26/2023

Long-term Safety, Tolerability, and Effectiveness of TV-46000, a Long-Acting Subcutaneous Antipsychotic (LASCA), in Patients With Schizophrenia (SHINE)

TV-46000 is a long-acting subcutaneous antipsychotic (LASCA). The SHINE study evaluated the long-term safety, tolerability, and effect of TV-46000 once monthly (q1m) and once every two mo...

10/26/2023

Tracks

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

Major Depressive Disorder

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products